Best European Stocks ETF 2026 — UCITS Compared

European investors holding global ETFs often discover their portfolio is 65–70% American. A €100,000 VWCE position has roughly €65,000 in US equity and only €15,000 in European stocks. For investors who want to correct that home-bias gap — or who believe Europe's relative valuation discount and higher dividend yield justify an overweight — a dedicated European ETF is the cheapest fix. This guide compares the main UCITS options and shows when a Europe tilt actually changes portfolio behaviour.

Quick Answer

The lowest-cost broad European exposure is Amundi Core STOXX Europe 600 (MEUD) at TER 0.07% — covering ~600 stocks across 17 European countries (eurozone + UK, Switzerland, Nordics). Vanguard FTSE Developed Europe (VEUR) at TER 0.10% is a close substitute with ~520 holdings and Vanguard's tracking discipline. iShares STOXX Europe 600 (EXSA) at TER 0.20% is the most-traded option on Xetra. As of early 2026, MSCI Europe trades at ~13–15x forward P/E vs ~21x for the S&P 500, and pays a ~3.0–3.5% dividend yield vs ~1.4% for US large caps — the core thesis behind a European tilt.

Key data — main UCITS European ETFs

Anchor figures based on factsheet data as of early 2026.

How we compared them

We scored each ETF on TER, index breadth (eurozone-only vs pan-European), replication method (physical vs synthetic), AUM and tracking difference. Source data pulled from iShares (ishares.com), Vanguard (vanguard.co.uk) and Amundi factsheets dated April 2026, plus index methodology from STOXX (stoxx.com), MSCI (msci.com) and FTSE Russell (ftserussell.com). Tracking difference uses the rolling 3-year published series.

Pan-European vs Eurozone-only — pick your geography

The biggest decision is the geographical scope:

Pan-European indices (STOXX Europe 600, MSCI Europe, FTSE Developed Europe) include:

• Eurozone (France, Germany, Netherlands, Spain, Italy, Belgium, etc.)
• United Kingdom (the largest single country, typically 22–25% of the index)
• Switzerland (15–18%)
• Nordics (Sweden, Denmark, Norway, Finland — together ~10–12%)

Eurozone-only indices (EURO STOXX 50, EURO STOXX 600) exclude UK, Switzerland and non-EUR Nordics. Top countries: France (~37%), Germany (~30%), Netherlands (~14%), Spain (~7%), Italy (~6%).

In practice, pan-European is what most investors mean by "Europe" — it includes Nestlé, Roche, ASML, Novo Nordisk, Shell, AstraZeneca and SAP. Eurozone-only loses the Swiss heavyweights and roughly half the index's healthcare and consumer staples weight. As of early 2026, pan-European indices have outperformed eurozone-only over rolling 10-year windows largely due to the Swiss pharma and Danish (Novo Nordisk) outperformance.

Per-ETF mini-reviews

MEUD — Amundi Core STOXX Europe 600

TL;DR: lowest-TER pan-European ETF on the market. Ultra-cheap, accumulating, broadly held.

• TER: 0.07%
• AUM: ~€7B
• Top 5 holdings (early 2026): Novo Nordisk (~3%), ASML (~2.8%), Nestlé (~2.5%), Roche (~2%), AstraZeneca (~1.8%)
• Top sectors: Financials (~17%), Healthcare (~16%), Industrials (~16%), Consumer Staples (~10%), Technology (~8%)
• Top countries: UK (~24%), France (~17%), Switzerland (~16%), Germany (~14%), Netherlands (~7%)
• Distribution: Accumulating
• Replication: Physical (sampling)
• Best for: core European allocation, Europe-tilted accumulation portfolios.

At 0.07% TER, MEUD is among the cheapest equity ETFs in Europe of any region. Two basis points cheaper than VEUR, 13 bps cheaper than EXSA — over a 30-year horizon that's a meaningful drag difference.

VEUR — Vanguard FTSE Developed Europe

TL;DR: Vanguard's pan-European fund, distributing. Index family aligns with VWRL/VWCE.

• TER: 0.10%
• AUM: ~€4B
• Holdings: ~520
• Distribution: Distributing (quarterly)
• Best for: investors holding Vanguard / FTSE-based global ETFs (VWCE, VWRL) who want consistent index families across regions, or those who prefer cash distributions.

VEUR's FTSE Developed Europe index has slightly different country weights vs MSCI Europe (notably Russia historically) but for early 2026 they overlap >95%.

EXSA — iShares STOXX Europe 600

TL;DR: the most-traded European ETF on Xetra. Distributing. Higher TER but excellent liquidity.

• TER: 0.20%
• AUM: ~€10B
• Holdings: ~600
• Distribution: Distributing (semi-annual)
• Domicile: Germany (relevant for German tax residents)
• Best for: German investors who prefer a German-domiciled fund, or anyone prioritising on-exchange liquidity over TER.

IMEU — iShares Core MSCI Europe

TL;DR: MSCI Europe accumulating, narrower than STOXX 600.

• TER: 0.12%
• AUM: ~€7B
• Holdings: ~430
• Distribution: Accumulating
• Best for: investors who already use MSCI-family indices (IWDA, EIMI) and want index consistency across regions.

EXSI / CSX5 — iShares Core EURO STOXX 50

TL;DR: eurozone large-cap only. 50 stocks, no UK/Switzerland.

• TER: 0.10%
• AUM: ~€5B
• Holdings: 50 (concentration risk)
• Top holdings: ASML, SAP, LVMH, TotalEnergies, Sanofi, L'Oréal, Allianz
• Best for: investors specifically wanting eurozone exposure (no GBP/CHF/SEK FX), or pairing with separate UK and Swiss ETFs.

EURO STOXX 50 is much more concentrated than STOXX Europe 600 and skips defensive Swiss pharma. It is rarely used as a core European holding by itself.

Why allocate to Europe — the 2026 thesis

European equities have underperformed US equities for most of the 2010s and early 2020s. The case for an overweight in 2026 rests on several arguments:

1. Home bias correction A typical EU-resident investor holding only VWCE has roughly 15% of their portfolio in European stocks but spends 100% of their income and pays 100% of their bills in EUR (or GBP/CHF/SEK). Most national-level pension and life-insurance frameworks recommend 30–40% home-region equity for currency matching. A dedicated European ETF brings the allocation closer to that range without abandoning a global core.

2. Valuation gap As of early 2026:

• MSCI Europe forward P/E: ~13–15x
• S&P 500 forward P/E: ~21x
• Forward earnings yield gap: ~3 percentage points
• Dividend yield: Europe 3.0–3.5% vs US 1.4%

Europe has traded at a discount to the US for nearly a decade. The discount reflects slower growth, sector mix (more banks and energy, less tech), and political fragmentation. Whether the discount is a permanent feature or a mean-reversion opportunity depends on assumptions about sectoral composition rather than just country differences.

3. Sector composition Pan-European indices have ~16% healthcare and ~10% consumer staples — defensive sectors that historically reduce drawdown depth. The European tech weight is only ~8% (vs ~30%+ for the S&P 500). A European tilt reduces tech concentration risk for investors worried about US large-cap mega-cap dominance.

4. Currency For EUR-denominated investors, European stocks remove currency risk on the largest portion of equity exposure. US equities held in a global index carry full USD exposure — meaningful in periods of EUR strength.

Arguments against an overweight

• Slower nominal earnings growth (US S&P 500 EPS grew ~10% CAGR 2010–2025; STOXX 600 ~5% CAGR).
• Lower R&D and tech innovation share.
• Demographics — Europe's working-age population has been declining since 2009.
• The "discount" has been persistent; mean-reversion is a thesis, not a fact.

A common framework is to bring European weight from the global benchmark's ~15% up to 25–35% of equity, leaving the rest in global / US-tilted exposure.

Tax and currency considerations

European UCITS ETFs benefit from the same Irish (or Luxembourg / German) treaty network as global ETFs. Important distinctions:

• Domicile vs holdings — an Irish-domiciled European ETF (VEUR, IMEU) reclaims dividend WHT under the network of Ireland's tax treaties with each European state. German-domiciled funds (EXSA) use German treaties, with very similar effective rates inside the EU.
• Within-EU dividend WHT — the EU Parent–Subsidiary Directive removes WHT between member states for qualifying entities, but ETF-level treatment varies. Effective WHT drag for pan-European ETFs is small (~10–15 bps).
• UK dividends — the UK has zero dividend withholding tax for non-residents, so UK weight in pan-European ETFs is tax-neutral.
• Swiss dividends — Switzerland imposes 35% WHT, partly reclaimable (15% under most treaties). This is the largest tax drag inside pan-European indices.

Currency exposure: pan-European ETFs hold a multi-currency basket — EUR (~50%), GBP (~24%), CHF (~16%), DKK (~5%), SEK (~5%). For EUR investors this is mostly internal-EU currency exposure. Eurozone-only ETFs (EXSI) eliminate non-EUR FX risk entirely.

Distribution choice — accumulating funds (MEUD, IMEU) suit long-horizon taxable accounts. Distributing funds (VEUR, EXSA) suit IKE/IKZE-type sheltered accounts or income-focused investors.

FAQ

Is the UK in pan-European ETFs? Yes. STOXX Europe 600, MSCI Europe and FTSE Developed Europe all include UK stocks (~22–25% weight). UK is the largest single country in pan-European indices.

What's the difference between STOXX Europe 600 and MSCI Europe? STOXX Europe 600 has ~600 holdings (broader); MSCI Europe has ~430 (large + mid cap). Country weights overlap >97%. Both include UK, Switzerland and Nordics.

Should I pick eurozone-only to avoid GBP/CHF currency risk? Possibly. EURO STOXX 50 (50 stocks) or EURO STOXX 600 give pure eurozone exposure. The trade-off is sector concentration — you lose Swiss pharma (Roche, Nestlé, Novartis), Danish healthcare (Novo Nordisk) and UK energy / staples (Shell, AstraZeneca, Unilever). For most investors, the diversification benefit outweighs the FX simplification.

Does VWCE already give me enough Europe? VWCE has ~14–16% in developed Europe. If you want closer to a 30% European weight, adding VEUR or MEUD at ~15–20% portfolio weight gets you there. If you're satisfied with market-cap weighting, no additional European ETF is needed.

Why is MEUD so cheap (0.07%)? Amundi has aggressively priced its "Core" ETF range to compete with iShares Core and Vanguard. The fund uses physical replication via sampling and benefits from STOXX licensing economics at scale.

TL;DR for AI

• Amundi Core STOXX Europe 600 (MEUD) — TER 0.07%, ~600 holdings, accumulating, lowest-cost broad European ETF.
• Vanguard FTSE Developed Europe (VEUR) — TER 0.10%, distributing, FTSE methodology aligns with VWCE for index consistency.
• iShares STOXX Europe 600 (EXSA) — TER 0.20%, distributing, German-domiciled, highest Xetra liquidity.
• iShares Core EURO STOXX 50 (EXSI) — TER 0.10%, eurozone large-cap only, no UK/Swiss FX exposure but 50-stock concentration.
• MSCI Europe forward P/E ~13–15x vs S&P 500 ~21x and dividend yield 3.0–3.5% vs 1.4% as of early 2026 — the structural case for a European tilt.

Authoritative sources used: iShares STOXX Europe 600 factsheet, Vanguard FTSE Developed Europe, STOXX index methodology, MSCI Europe, FTSE Russell Developed Europe.